Problems in Cardiopulmonary Bypass - PowerPoint PPT Presentation

1 / 32
About This Presentation
Title:

Problems in Cardiopulmonary Bypass

Description:

Problems in Cardiopulmonary Bypass Introduction Perfusion Incident frequency Identify possible problems during CPB Outline remedial action Incident Frequency Incident ... – PowerPoint PPT presentation

Number of Views:1693
Avg rating:3.0/5.0
Slides: 33
Provided by: Peter1390
Category:

less

Transcript and Presenter's Notes

Title: Problems in Cardiopulmonary Bypass


1
Problems in Cardiopulmonary Bypass
2
Introduction
  • Perfusion Incident frequency
  • Identify possible problems during CPB
  • Outline remedial action

3
Incident Frequency
Date Author Country Incidence / accidents Permanent injury/death
1980 Stoney US 1 / 300 1 / 1000
1981 Wheeldon UK 1 / 300 1 / 1500
1986 Kuruz US 1 / 100 1 / 1000
1997 Jenkins Australia 1 / 35 1 / 1300
2000 Mejak US 1 / 130 1 / 1400
4
Incident distribution
Stoney Wheeldon Kuruz Jenkins Mejak
DIC Elec failure Protamine reaction Heater/cooler problems DIC
air embolism air embolism Oxy failure air embolism Protamine reaction
Elec failure Oxy failure Elec / mech failure Protamine reaction/prob Ao dissection / cannula prob
Mech failure Mech failure Drug error Oxy failure Oxy failure
Oxy failure DIC air embolism air embolism
DIC
5
Topics for Discussion
  • Mediation of Patients immune system response
  • Unusual syndromes
  • Oxygenator problems
  • Embolic events ? Protocol for Gross Air
    Embolism

6
Systemic Inflammatory response
  • Platelet adhesion, activation of Factor XII
  • Cascade activation
  • kallikrein
  • kinin-bradykinin
  • Fibrinolytic
  • Complement - ? C3a C5a
  • leucocyte activation
  • ? oxygen free radicals

7
Mediation of Inflammatory response
  • 1. Biocompatible materials
  • Albumin in priming fluid
  • Heparin coating - ionic -
    benzalkonium heparin
  • surface grafting -
  • covalent -
    Carmeda
  • Endothelial-like surfaces -
    phosphorylcholine
  • trillium

8
(No Transcript)
9
(No Transcript)
10
(No Transcript)
11
Mediation of Inflammatory response
  • Leucocyte depletion
  • 3. Isolation of Cardiotomy suction

12
Anti-thrombin III deficiency
  • In the absence of adequate circulating AT-III
    heparin has little or no effect retarding blood
    coagulation.
  • Congenital AT-III deficiency
  • Acute venous thrombosis
  • DIC
  • Liver cirrhosis

13
AT III - Diagnosis action
  • ACT still low after Heparin bolus
  • Repeat bolus ( 30 - 40mg / Kg )
  • ACT still low give 2 units FFP
  • Recheck ACT
  • On bypass add further FFP as reqd

14
Microaggregates - Cold agglutinins
  • gp1 Immunoglobulin M class directed against
    erythrocyte I antigen wide thermal range 4 to
    32?C
  • gp2 narrow thermal range 0 - 10?C
  • Clotting / grainy appearance
  • Interfere with cardioplegia distribution ?
    myocardial protection.

15
Cold agglutinins management strategy
  • Rewarm pat to 320C
  • Switch to warm blood cardioplegia
  • Sample to haematology to determine thermal
    amplitude
  • Pre-op plasmapheresis for patients with known
    agglutinins will remove most of the serum
    antibodies.

16
Malignant Hyperthermia
  • Inherited disorder rapid ?temp to 42C in
    response to volatile anaesthetic agents
  • Abnormal calcium metabolism - ?myoplasmic ionic
    calcium
  • ?Metabolic rate, resp met acidosis,? K , ?
    lactate pyruvate, tachycardia, ? temp
  • Massive muscle swelling, Pul oedema, DIC acute
    renal failure ? ? 70 mortality

17
M.H. - remedial action
  • Stop all volatile anaesthetic agents
  • ?FiO2 to meet ?metabolic demand
  • Administer Dantrolene sodium IV
  • Correct acidosis hyperkalaemia
  • Use IV and surface cooling to control temp
  • Give mannitol frusemide to maintain urine
    output of at least 2ml/Kg/hr

18
Sickle Cell Disease
  • Low O2 sat /- hypothermia will cause sickle
    cells to clump precipitate
  • Disease Pats with ?50 Haemoglobin S cells
    will sickle _at_ ? 85 O2 sat
  • Trait Pats with ?45 Haemoglobin S
    cells will sickle _at_ ? 40 O2 sat

19
Sickle Cell Disease management strategy
  • Disease
  • Trait

Divert venous blood to cell salvage /
plasmapheresis to separate plasma and
platelets Replace with RBC, FFP, colloid
crystalloid
Keep O2 saturations high Avoid acidosis Avoid
hypothermia Warm blood cardioplegia
20
Methaemoglobinaemia
  • Severe cyanosis of arterial blood ( often appears
    chocolate brown rather than blue ) in spite of
    high pO2
  • Haem ion oxidised from ferrous (Fe 2) to ferric
    (Fe 3) state
  • Hereditary deficiency in control enzymes
  • Drug reaction e.g. nitroglycerine, isosorbide
    dinitrate, sodium nitrate

21
Remedial Action
  • Withdraw all possible causative agents
  • Administer 1 methylene blue infusion 1
    3mg/kg over 5 min
  • Doses gt 7mg/kg are toxic
  • High dose Vitamin C and/or exchange transfusion
    in severe cases

22
Oxygenator Problems
  • Physical attrition
  • ? Gas exchange capability
  • Inadequate anticoagulation
  • Heparin resistance
  • AT III deficiency
  • Administration of Protamine !

23
Sources of Emboli
  • Particulate
  • Oxygenator - Polypropylene / polycarbonate
  • CPB circuit - PVC / silicone (spallation)
  • Patient - plaque
  • calcium
  • platelet / fibrin aggregates
  • lipid globules
  • muscle / connective tissue fragments

24
Sources of Emboli
  • Gaseous
  • Cannulation
  • Venous air entrainment (VAVD?)
  • Inadequate de-airing of the heart
  • Inappropriate vent suction
  • Centrifugal pump retrograde flow
  • IABP deflation during aortotomy
  • Temperature Gradients
  • Catastrophic gross air embolism

25
Protection Against Embolic Events ( 1 )
  • Particulate

0.5 micron Pre-bypass filter 40 micron
Arterial line filter 120 micron cardiotomy
reservoir filter
26
Protection Against Embolic Events ( 2 )
  • Gaseous
  • Microemboli - arterial line filter purge
    line
  • - elimination of entrained venous air
  • - vent line one-way pressure relief valves
  • Macroemboli - oxygenator resevoir level sensor
  • - arterial line filter purge line
    - ultrasonic
    bubble detector in art line
  • - anti-siphon valve /
    software for centrifugal
    pumps
  • - CO2 insufflation

27
Gross Air Embolism Incident - Protocol
  • Perfusion
  • Surgical
  • Anaesthetic
  • Post operative care

28
Perfusion
  • Discontinue bypass clamp art ven lines
  • Identify origin of problem
  • Reprime CPB circuit art cannula
  • Retrograde SVC perfusion 1-2 LPM
  • Reinstitute bypass - ? temp (22 30o C)
    ?Systemic
    pressure
    FiO2 100
  • Off bypass _at_ 34o C

29
Surgical
  • Clamp remove aortic cannula
  • Cannulate SVC or connect to SVC cannula
  • Retrieve blood/air exiting aorta via vent
  • When no more air is visible at aortotomy --
    Re-cannulate aorta reinstitute bypass
  • Bleed air from coronary arteries
  • Complete Surgical procedure

30
Anaesthetic
  • Place patient in steep Trendelenberg position
  • Compress carotid arteries
  • Consider administering
  • Steroids
  • Mannitol
  • Antiplatelet agents

31
Post Bypass Management
  • Ventilate patient on 100 oxygen
  • Institute slight hyperventilation
  • Rewarm to normothermia over 24hrs
  • Place patient in reverse trendelenberg posn
  • Avoid hyperglycaemia hyponatraemia
  • Consider Hyperbaric oxygen treatment

32
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com